DAVID GRANOVSKY

SYMPOWERCO CORP (PINK:SYMW) Is The Top Traded OTC Stock

In BUSINESS OF STEM CELLS on August 25, 2009 at 9:49 pm

HARD TO TREAT DISEASES (PINK:HTDS) is trading up 5% at $0.0103 on huge volume of 87 million shares. Yesterday, 24 August, Hard to Treat Diseases (HTDS.PK) Dr. Sanja Pekovic, Chief Project Scientist, Chief Strategy Officer Slavica BioChem reported that IBISS research group from Serbia has begun preliminary experiments within a project aimed at Promoting stem cell graft survival in the model of traumatic brain injury in rats. One of the goals of this project is to examine the potential role of Ribavirin in promoting survival of the stem cells transplanted after brain injury.

via SYMPOWERCO CORP (PINK:SYMW) Is The Top Traded OTC Stock.

About these ads

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 3,078 other followers

%d bloggers like this: